Younger children across the US are now eligible to receive a Covid-19 booster shot developed by Pfizer Inc. and BioNTech SE after the head of the Centers for Disease Control and Prevention granted the final clearance needed for injections to begin.

Hospira Inc.’s generic version of Astellas Pharma Inc.’s Lexiscan doesn’t infringe three patents covering the drug, a Delaware federal judge ruled.

Nektar Therapeutics fought off an attempt to revive a securities suit over the company’s statements about its cancer drug trial results after the Ninth Circuit said Monday investors failed to allege falsity or loss causation.

The head of the FDA says the agency needs more resources to speed up its review of e-cigarettes and is avoiding making hasty decisions that could incite lawsuits from the industry.

The US Food and Drug Administration denied two petitions from environmental and health advocates to ban food packaging phthalates and accepted an industry group’s petition to stop authorizing phthalates no longer used in food containers, the agency said Thursday.

Oklahoma’s state legislature on Thursday approved a near-total abortion ban, building on past laws that include a Texas-style prohibition after about six weeks of pregnancy and a so-called trigger ban that would take effect should Roe v. Wade be overturned.